1. Home
  2. WST vs MTZ Comparison

WST vs MTZ Comparison

Compare WST & MTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • MTZ
  • Stock Information
  • Founded
  • WST 1923
  • MTZ 1929
  • Country
  • WST United States
  • MTZ United States
  • Employees
  • WST N/A
  • MTZ N/A
  • Industry
  • WST Medical/Dental Instruments
  • MTZ Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • WST Health Care
  • MTZ Industrials
  • Exchange
  • WST Nasdaq
  • MTZ Nasdaq
  • Market Cap
  • WST 15.6B
  • MTZ 13.6B
  • IPO Year
  • WST N/A
  • MTZ N/A
  • Fundamental
  • Price
  • WST $263.31
  • MTZ $186.18
  • Analyst Decision
  • WST Buy
  • MTZ Strong Buy
  • Analyst Count
  • WST 7
  • MTZ 20
  • Target Price
  • WST $332.50
  • MTZ $173.74
  • AVG Volume (30 Days)
  • WST 852.1K
  • MTZ 877.4K
  • Earning Date
  • WST 07-24-2025
  • MTZ 07-31-2025
  • Dividend Yield
  • WST 0.33%
  • MTZ N/A
  • EPS Growth
  • WST N/A
  • MTZ N/A
  • EPS
  • WST 6.68
  • MTZ 2.70
  • Revenue
  • WST $2,960,200,000.00
  • MTZ $12,464,333,000.00
  • Revenue This Year
  • WST $3.38
  • MTZ $12.36
  • Revenue Next Year
  • WST $5.82
  • MTZ $9.01
  • P/E Ratio
  • WST $39.42
  • MTZ $68.85
  • Revenue Growth
  • WST 2.90
  • MTZ 3.03
  • 52 Week Low
  • WST $187.43
  • MTZ $89.96
  • 52 Week High
  • WST $352.33
  • MTZ $188.74
  • Technical
  • Relative Strength Index (RSI)
  • WST 67.71
  • MTZ 73.96
  • Support Level
  • WST $206.80
  • MTZ $167.26
  • Resistance Level
  • WST $291.00
  • MTZ $178.93
  • Average True Range (ATR)
  • WST 8.40
  • MTZ 4.29
  • MACD
  • WST 4.53
  • MTZ 0.73
  • Stochastic Oscillator
  • WST 67.11
  • MTZ 90.19

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About MTZ MasTec Inc.

MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. The company's primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; oil and gas; power delivery; and other.

Share on Social Networks: